Hepatic failure, not elsewhere classified

K11_HEPFAIL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K72 Hospital discharge: ICD-9 — 570 Hospital discharge: ICD-8 — 570 Hospital discharge: excluded ICD-8 — 57001 Cause of death: ICD-10 — K72 Cause of death: ICD-9 — 570 Cause of death: ICD-8 — 570 Cause of death: excluded ICD-8 — 57001 2 out of 7 registries used, show all original rules.	1299
4. Check minimum number of events None	1299
5. Include endpoints None	1299
6. Filter based on genotype QC (FinnGen only)	1299

Control definitions (FinnGen only)

Control exclude: K11_LIVER

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K70-K77
Name in latin: Insufficientia hepatis non alibi classificata

NAME	K11_HEPFAIL
CONTROL_EXCLUDE	K11_LIVER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K72
HD_ICD_9	570
HD_ICD_8	570
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL	57001
COD_MAINONLY
COD_ICD_10	K72
COD_ICD_9	570
COD_ICD_8	570
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL	57001
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hepatic failure, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13134	5721	7234
Only index persons	9949	4454	5495
Unadjusted period prevalence (%)
Whole population	0.19	0.16	0.20
Only index persons	0.19	0.16	0.21
Median age at first event (years)
Whole population	60.26	60.66	59.96
Only index persons	60.52	60.24	60.75

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1299	597	702
Unadjusted period prevalence (%)	0.26	0.20	0.31
Median age at first event (years)	59.47	56.63	61.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1152: Matched controls
11521

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K72.9

ICD-10 Finland

Hepatic failure, unspecified

8753.2

323.0

516

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

+∞

323.0

473

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2407.0

225.6

211

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

+∞

192.2

179

C03DA01

ATC

spironolactone; oral

9.4

175.5

411

639

K72.1

ICD-10 Finland

Chronic hepatic failure

+∞

174.5

163

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

10.8

168.2

357

461

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

7.2

147.8

421

853

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

41.3

147.1

185

R18

ICD-10 Finland

Ascites

45.8

145.5

179

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

245.9

129.8

131

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.4

114.9

583

2164

C03CA01

ATC

furosemide; systemic

4.1

105.0

587

2325

Z94.4

ICD-10 Finland

Liver transplant status

225.8

101.2

103

A06AD11

ATC

lactulose; oral

5.0

99.2

379

1022

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

28.2

90.0

124

JJC00

NOMESCO Finland

Allogenic transplantation of liver

926.5

88.9

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

+∞

88.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.3

82.8

368

1125

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

26.2

81.2

114

N17.9

ICD-10 Finland

Acute renal failure, unspecified

9.9

80.9

171

199

K70.4

ICD-10 Finland

Alcoholic hepatic failure

+∞

80.1

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.8

72.4

196

335

127

Kela drug reimbursment

Transplant complication

20.6

72.1

109

K70.1

ICD-10 Finland

Alcoholic hepatitis

697.3

67.7

K76.9

ICD-10 Finland

Liver disease, unspecified

180.4

65.7

A05AA02

ATC

ursodeoxycholic acid; oral

23.7

61.1

57009

ICD-8 Finland

Acute and subacute necrosis of liver, Unspecified

+∞

61.0

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

607.9

59.2

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

607.9

59.2

A07AA11

ATC

rifaximin; oral

596.8

58.2

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.9

57.9

174

336

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

46.4

57.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.6

56.6

307

1064

TK800

NOMESCO Finland

Hemodialysis

11.6

56.4

108

102

L04AA06

ATC

mycophenolic acid; systemic

16.2

54.7

K76.7

ICD-10 Finland

Hepatorenal syndrome

+∞

51.4

D64.9

ICD-10 Finland

Anaemia, unspecified

4.0

51.3

229

667

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

111.0

49.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

49.0

627

3693

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

31.2

48.9

K70.0

ICD-10 Finland

Alcoholic fatty liver

174.0

48.2

A41.9

ICD-10 Finland

Sepsis, unspecified

8.0

47.8

113

155

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

+∞

47.2

WX872

NOMESCO Finland

Intensive care

5.2

42.8

142

304

C07AA05

ATC

propranolol; systemic

2.9

41.1

290

1179

AA1AD

NOMESCO Finland

CT of head and brain

2.6

40.5

382

1849

JJ5AT

NOMESCO Finland

411.2

40.3

L04AD01

ATC

ciclosporin; systemic

10.1

40.2

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

4.3

40.1

159

409

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

400.4

39.3

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

38.8

335

1533

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

24.6

38.2

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

35.7

37.5

A02BC02

ATC

pantoprazole; systemic

2.3

35.9

802

5799

K92.0

ICD-10 Finland

Haematemesis

8.0

34.5

106

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

22.2

33.7

L04AX01

ATC

azathioprine; systemic

5.8

33.5

184

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.2

33.2

194

683

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

32.9

198

712

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

+∞

32.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.4

32.1

101

202

UJK02

NOMESCO Finland

ERCP

8.0

31.6

K83.0

ICD-10 Finland

Cholangitis

11.9

31.3

N02AA05

ATC

oxycodone; systemic

2.7

30.8

238

1005

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.8

30.5

163

A10AE04

ATC

insulin glargine; parenteral

3.3

30.1

163

542

P15

ICPC

Chronic alcohol abuse

6.9

29.8

116

N02AX02

ATC

tramadol; systemic, rectal

2.1

29.7

548

3519

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

29.6

423

2437

WW500

NOMESCO Finland

Blood transfusion

4.9

29.5

101

222

JN3AD

NOMESCO Finland

Abdominal CT examination

3.6

29.4

143

437

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

29.3

187

696

R50.9

ICD-10 Finland

Fever, unspecified

2.8

29.3

215

876

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

11.5

29.3

D97

ICPC

Liver disease NOS

58.3

29.2

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

8.0

29.1

K74.3

ICD-10 Finland

Primary biliary cirrhosis

299.1

28.9

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

8.1

28.5

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

28.0

339

1800

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.8

27.9

124

351

WX892

NOMESCO Finland

Monitored bed care

3.4

27.7

143

457

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.4

27.6

170

G93.4

ICD-10 Finland

Encephalopathy, unspecified

48.4

27.5

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

8.1

27.5

R11

ICD-10 Finland

Nausea and vomiting

3.5

27.4

136

421

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

+∞

27.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.6

26.4

128

389

57008

ICD-8 Finland

Acute and subacute necrosis of liver, Alii definiti

+∞

26.1

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.4

26.1

115

K92.1

ICD-10 Finland

Melaena

4.0

26.0

108

287

N17.8

ICD-10 Finland

Other acute renal failure

11.6

25.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.3

25.1

236

JN4AD

NOMESCO Finland

Body CT examination

3.2

24.8

138

464

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.1

24.7

148

524

H02AB04

ATC

methylprednisolone; systemic

2.6

24.6

206

900

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.6

24.1

202

UJF32

NOMESCO Finland

Coloscopy

2.1

24.1

341

1918

F10.25

ICD-10 Finland

Alcohol dependence continuous use

9.0

24.0

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

8.8

23.7

JN4BD

NOMESCO Finland

Extensive body CT

2.7

23.5

176

721

N19

ICD-10 Finland

Unspecified kidney failure

4.9

23.4

171

103

Kela drug reimbursment

Diabetes, insulin-treated

2.1

23.4

354

2043

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.8

23.3

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.1

22.9

247

B18.2

ICD-10 Finland

Chronic viral hepatitis C

14.5

22.7

I50.9

ICD-10 Finland

Heart failure, unspecified

2.4

22.7

212

980

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.9

22.7

ZX120

NOMESCO Finland

Intravenous

2.8

22.3

155

604

J01MA12

ATC

levofloxacin; systemic

2.2

22.3

254

1290

WX882

NOMESCO Finland

High dependency care

5.4

22.1

133

K71.2

ICD-10 Finland

Toxic liver disease with acute hepatitis

+∞

21.9

J01MA02

ATC

ciprofloxacin; systemic

1.9

21.6

489

3262

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

8.5

21.5

K83.1

ICD-10 Finland

Obstruction of bile duct

10.3

21.4

N07BB01

ATC

disulfiram; oral

4.2

21.3

208

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

13.1

21.2

H02AB06

ATC

prednisolone; systemic

1.8

21.2

560

3925

N05AH04

ATC

quetiapine; oral

2.4

21.1

208

983

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

21.0

310

1759

N06AX11

ATC

mirtazapine; oral

1.9

21.0

370

2250

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

37.9

20.8

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.1

20.8

A28

ICPC

Limited function/disability NOS

2.3

20.6

217

1061

A09AA02

ATC

multienzymes (lipase, protease etc.)

6.8

20.4

N05CF01

ATC

zopiclone; oral

1.9

20.3

400

2526

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.7

20.2

147

589

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

19.7

175

782

A98

ICPC

Health maint/preventive medicine

0.5

19.3

873

9954

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.1

19.2

114

400

F10.24

ICD-10 Finland

Alcohol depence active use

8.3

19.1

TK810

NOMESCO Finland

Hemofiltration

13.0

19.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

18.8

398

2561

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.3

18.4

172

A41.8

ICD-10 Finland

Other specified sepsis

7.1

18.3

TKC20

NOMESCO Finland

Catheterisation of bladder

2.9

18.3

119

445

K76.6

ICD-10 Finland

Portal hypertension

+∞

17.7

K75.4

ICD-10 Finland

Autoimmune hepatitis

+∞

17.7

JN4CD

NOMESCO Finland

Very extensive body CT

3.9

17.7

199

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.5

17.6

247

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

182.6

17.6

N05BA04

ATC

oxazepam; oral

1.9

17.5

290

1702

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

17.4

146

633

A46

ICD-10 Finland

Erysipelas

2.2

17.4

198

998

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

17.0

151

672

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.4

16.8

148

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

7.4

16.6

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.1

16.5

327

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

20.4

16.5

F05.9

ICD-10 Finland

Delirium, unspecified

5.6

16.5

WX002

NOMESCO Finland

Sedation and analgesia

2.0

16.4

246

1386

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

7.9

16.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.3

16.4

152

R41.0

ICD-10 Finland

Disorientation, unspecified

4.2

16.3

153

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

13.0

16.2

L28

ICPC

Limited function/disability (L)

2.1

16.2

203

1063

C07AG02

ATC

carvedilol; oral

2.9

16.0

352

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.3

15.9

142

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

12.4

15.9

P16

ICPC

Acute alcohol abuse

7.7

15.7

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

6.2

15.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

15.7

171

842

E87.6

ICD-10 Finland

Hypokalaemia

4.2

15.6

150

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

8.7

15.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.5

15.5

217

I50.0

ICD-10 Finland

Congestive heart failure

2.6

15.4

113

455

Z51.5

ICD-10 Finland

Palliative care

2.9

15.1

353

UJD02

NOMESCO Finland

Gastroscopy

3.3

15.1

255

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.9

15.1

336

A10AE05

ATC

insulin detemir; parenteral

3.0

15.1

301

SPAT1254

SPAT

Administration of medicine

2.1

15.0

183

947

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

7.1

14.9

R4110

NOMESCO Finland

Physiotherapy

1.8

14.8

318

2026

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

14.7

177

907

I81

ICD-10 Finland

Portal vein thrombosis

21.3

14.7

57309

ICD-8 Finland

Other diseases of liver, Unspecified

+∞

14.6

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

14.6

367

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

6.9

14.3

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.9

14.1

R53

ICD-10 Finland

Malaise and fatigue

1.9

14.0

236

1380

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

10.2

14.0

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

14.0

240

1412

A02BC01

ATC

omeprazole; systemic

1.7

13.9

322

2091

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

12.9

13.9

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.0

13.8

294

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

9.2

13.7

SPAT1262

SPAT

Handing over of treatment supplies

1.9

13.6

222

1281

K74.0

ICD-10 Finland

Hepatic fibrosis

+∞

13.6

57300

ICD-8 Finland

Other diseases of liver, Hepatitis NUD

+∞

13.6

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

13.4

312

2026

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

13.3

396

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

13.3

283

1789

N05CD07

ATC

temazepam; oral

2.1

13.2

162

836

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

13.1

124

568

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.9

13.1

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

7.5

13.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

13.0

195

1093

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.7

12.8

WX730

NOMESCO Finland

Conventional respirator

5.5

12.8

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

5.7

12.8

R94.5

ICD-10 Finland

Abnormal results of liver function studies

9.8

12.8

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

12.7

217

1268

Z72.1

ICD-10 Finland

Alcohol use

6.9

12.7

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.4

12.6

187

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.4

12.6

111

494

N18.8

ICD-10 Finland

Other chronic renal failure

4.0

12.5

130

JCA20

NOMESCO Finland

Ligature of oesophageal varices

+∞

12.5

K76.89

ICD-10 Finland

Other specified diseases of liver

+∞

12.5

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.9

12.4

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.4

12.4

106

461

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

12.2

187

1050

K29.7

ICD-10 Finland

Gastritis, unspecified

3.6

12.1

160

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

12.1

212

1251

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

12.1

134

664

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

27.0

12.1

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

27.0

12.1

2BD01

NOMESCO Finland

21.5

12.0

P19

ICPC

Drug abuse

10.2

12.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

11.8

337

2305

N06AX16

ATC

venlafaxine; oral

2.1

11.8

146

754

RS220

NOMESCO Finland

6.7

11.8

N05BA01

ATC

diazepam; systemic, rectal

2.0

11.8

162

877

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

11.7

334

N06AB10

ATC

escitalopram; oral

1.9

11.7

200

1168

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

19.1

11.6

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

19.1

11.6

SPAT1216

SPAT

Assessment of functional ability

1.9

11.6

179

1011

A07EA06

ATC

budesonide; oral, local oral

3.8

11.5

130

L04AA01

ATC

[U] ciclosporin; systemic

5.5

11.5

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

6.8

11.5

57000

ICD-8 Finland

Acute and subacute necrosis of liver, Hepatitis acuta degenerativa

+∞

11.5

WW408

NOMESCO Finland

+∞

11.5

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

+∞

11.5

N30.0

ICD-10 Finland

Acute cystitis

2.0

11.5

148

780

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.5

11.4

152

A40.8

ICD-10 Finland

Other streptococcal sepsis

8.4

11.3

N06AB04

ATC

citalopram; systemic

1.8

11.3

232

1439

C07AB07

ATC

bisoprolol; oral

1.5

11.3

527

4072

E87.5

ICD-10 Finland

Hyperkalaemia

4.4

11.2

K29.6

ICD-10 Finland

Other gastritis

6.5

11.1

K86.1

ICD-10 Finland

Other chronic pancreatitis

8.1

11.1

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.7

11.1

135

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.2

11.1

T90

ICPC

Diabetes non-insulin dependent

1.7

11.1

259

1673

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.5

11.0

365

M04AA01

ATC

allopurinol; systemic

1.9

11.0

167

933

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

11.0

179

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

14.0

11.0

RS120

NOMESCO Finland

43.7

10.9

L04AA05

ATC

[U] tacrolimus; systemic

43.7

10.9

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

43.7

10.9

V03AE01

ATC

polystyrene sulfonate; oral

5.7

10.8

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.4

10.7

378

XW000

NOMESCO Finland

Bone marrow biopsy

2.8

10.7

246

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

10.6

173

993

A10BH01

ATC

sitagliptin; oral

2.1

10.5

118

586

ZX108

NOMESCO Finland

Inhalation

7.4

10.5

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

111.0

10.4

R60.0

ICD-10 Finland

Localized oedema

2.0

10.4

132

687

K71.1

ICD-10 Finland

Toxic liver disease with hepatic necrosis

+∞

10.4

B01AA03

ATC

warfarin; systemic

1.7

10.4

244

1571

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

16.2

10.4

E86

ICD-10 Finland

Volume depletion

3.9

10.4

107

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.2

10.3

171

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

10.3

419

3113

N03AX14

ATC

levetiracetam; systemic

3.7

10.3

123

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.0

10.3

197

N05BA02

ATC

chlordiazepoxide; systemic

3.8

10.3

113

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

9.2

10.0

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

4.2

10.0

J01FF01

ATC

clindamycin; systemic

1.6

10.0

299

2056

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.0

10.0

101

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.5

10.0

137

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.4

9.9

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

6.8

9.9

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

9.9

348

2494

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.0

9.9

199

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.7

9.8

246

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.2

9.7

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

5.2

9.7

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.6

9.7

124

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.2

9.7

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

55.4

9.7

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

9.7

275

I50.1

ICD-10 Finland

Left ventricular failure

2.7

9.7

250

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.9

9.6

N03AX16

ATC

pregabalin; oral

1.6

9.6

254

1689

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

9.6

234

1523

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.4

9.6

K86.3

ICD-10 Finland

Pseudocyst of pancreas

11.5

9.6

N05AH03

ATC

olanzapine; systemic

2.6

9.6

288

2BB01

NOMESCO Finland

100.8

9.4

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

+∞

9.4

5CM18

NOMESCO Finland

12.5

9.4

S97

ICPC

Chronic ulcer skin

2.4

9.3

326

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.6

9.3

113

SPAT1265

SPAT

Breathalyser

6.1

9.2

A10BB12

ATC

glimepiride; oral

2.2

9.2

439

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.5

9.2

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

11.6

9.1

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.2

9.1

148

JJA20

NOMESCO Finland

Open biopsy of liver

15.7

9.0

H26.3

ICD-10 Finland

Drug-induced cataract

9.1

9.0

A10BH05

ATC

linagliptin; oral

2.6

9.0

261

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.7

8.9

220

JAH00

NOMESCO Finland

Laparotomy

3.1

8.8

151

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

8.8

120

647

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.2

8.7

141

3A422

NOMESCO Finland

50.4

8.7

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.2

8.6

137

A04

ICPC

Weakness/tiredness general

1.9

8.6

134

758

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.0

8.5

K65.0

ICD-10 Finland

Acute peritonitis

6.5

8.5

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

27.7

8.5

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.9

8.5

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.0

8.5

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

8.4

446

R77.0

ICD-10 Finland

Abnormality of albumin

90.7

8.4

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

7.9

8.4

JJC60

NOMESCO Finland

Total excision of transplanted liver

+∞

8.3

K70

ICD-10 Finland

Alcoholic liver disease

+∞

8.3

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

+∞

8.3

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

6.3

8.3

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.5

8.3

108

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.0

8.3

152

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

8.3

258

WX704

NOMESCO Finland

Intubation

2.2

8.2

387

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

8.2

624

5204

B03XA02

ATC

darbepoetin alfa; parenteral

4.0

8.2

N06AX17

ATC

milnacipran; oral

6.1

8.2

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.4

8.2

A10BA02

ATC

metformin; oral

1.5

8.2

297

2129

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

5.7

8.2

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.0

8.0

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

9.0

8.0

C08CA01

ATC

amlodipine; oral

1.5

8.0

379

2875

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

22.2

8.0

R06.0

ICD-10 Finland

Dyspnoea

1.6

8.0

257

1785

SPAT1240

SPAT

Therapeutic discussion

2.0

7.9

508

RS230

NOMESCO Finland

13.1

7.9

N05BA12

ATC

alprazolam; oral

1.9

7.8

111

606

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

8.5

7.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

7.8

350

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

7.8

168

1050

SPAT1255

SPAT

Intravenous administration of medicine

2.1

7.8

403

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.4

7.7

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.6

7.7

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

7.7

178

1135

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

7.7

173

K85

ICD-10 Finland

Acute pancreatitis

4.2

7.6

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

25.2

7.6

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.4

7.6

101

3A064

NOMESCO Finland

8.9

7.5

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.5

7.5

1310

SPAT1263

SPAT

Sampling

1.4

7.5

433

3406

Z94.0

ICD-10 Finland

Kidney transplant status

4.9

7.5

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

5.1

7.4

SPAT1229

SPAT

Assessment of need for aid

2.0

7.4

464

B17.8

ICD-10 Finland

Other specified acute viral hepatitis

80.6

7.4

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.6

7.4

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.7

7.4

183

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.4

7.4

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

7.3

103

561

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

10.9

7.3

5700A

ICD-9 Finland

Acute and subacute necrosis of liver[NECROSIS HEPATIS TOXICA ACUTA, SINE COMATE HEPATICO]

+∞

7.3

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

7.3

195

H02AB09

ATC

hydrocortisone; systemic

3.4

7.3

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

15.8

7.2

3AC01

NOMESCO Finland

4.7

7.2

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

7.2

253

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

30.2

7.2

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

20.1

7.1

E66.8

ICD-10 Finland

Other obesity

2.5

7.1

206

J01MA14

ATC

moxifloxacin; systemic

1.9

7.1

502

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

7.1

180

1177

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

7.1

123

720

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

6.1

7.1

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

5.7

7.1

G41.9

ICD-10 Finland

Status epilepticus, unspecified

8.8

7.1

A07EC02

ATC

mesalazine; oral, rectal

2.3

7.0

270

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

7.0

237

1663

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.4

7.0

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

7.0

376

N06AX26

ATC

vortioxetine; oral

2.4

7.0

241

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

6.9

196

K50.9

ICD-10 Finland

Crohn disease, unspecified

5.5

6.9

E0000UV

ATC

1.4

6.9

386

3009

WX419

NOMESCO Finland

Other general anesthesy

4.8

6.9

R4190

NOMESCO Finland

Nutritional therapy

2.8

6.8

150

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

11.0

6.8

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

11.0

6.8

B01AB05

ATC

enoxaparin; parenteral

1.5

6.8

319

2402

TPX15

NOMESCO Finland

Removal of vascular injection port

9.4

6.8

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

9.4

6.8

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.6

6.8

184

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

16.8

6.7

F34.1

ICD-10 Finland

Dysthymia

2.9

6.7

138

J01DB01

ATC

cefalexin; oral

1.4

6.7

865

7801

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

6.7

320

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

6.7

207

1421

C01AA05

ATC

digoxin; systemic

1.9

6.7

100

560

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

6.6

118

F61.0

ICD-10 Finland

Mixed personality disorders

4.2

6.6

M10.9

ICD-10 Finland

Gout, unspecified

2.0

6.6

399

R40.2

ICD-10 Finland

Coma, unspecified

5.9

6.6

D07AC01

ATC

betamethasone; topical

1.4

6.6

347

2668

A07AA09

ATC

vancomycin; oral

4.1

6.6

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

12.3

6.6

198

Kela drug reimbursment

Sorafenib

12.3

6.6

SPAT1272

SPAT

Drug screening

12.3

6.6

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

6.5

282

2082

N05AA02

ATC

levomepromazine; systemic

2.4

6.5

220

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

10.1

6.5

OAB43

SPAT

0.4

6.5

761

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

6.5

113

663

E000001

ATC

1.5

6.5

208

1440

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.7

6.5

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.5

6.4

G92

ICD-10 Finland

Toxic encephalopathy

70.2

6.4

D72

ICPC

Viral hepatitis

70.2

6.4

S01.0

ICD-10 Finland

Open wound of scalp

1.9

6.4

474

J96.0

ICD-10 Finland

Acute respiratory failure

4.7

6.4

Z72.2

ICD-10 Finland

Drug use

7.4

6.4

L30.3

ICD-10 Finland

Infective dermatitis

2.8

6.4

138

S72.0

ICD-10 Finland

Fracture of neck of femur

2.5

6.4

187

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

14.4

6.4

A08

ICPC

Swelling

2.4

6.4

206

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

8.2

6.3

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

6.0

6.3

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.0

6.3

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

5.5

6.3

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

6.3

220

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

9.3

6.3

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

9.3

6.3

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

18.1

6.3

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.3

6.3

241

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

+∞

6.3

57308

ICD-8 Finland

Other diseases of liver, Alii definiti

+∞

6.3

Z944, K720

ICD-10 Finland

+∞

6.3

N06AB06

ATC

sertraline; oral

1.8

6.2

100

572

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.5

6.2

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

26.8

6.2

K85.8

ICD-10 Finland

Other acute pancreatitis

7.1

6.2

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

6.2

277

C10AA07

ATC

rosuvastatin; oral

0.6

6.2

116

1766

SPAT1247

SPAT

Outpatient detoxication and monitoring

7.7

6.1

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

6.1

440

F93.89

ICD-10 Finland

Other childhood emotional disorders

12.6

6.1

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

12.6

6.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

6.1

307

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.9

6.1

A12BA01

ATC

potassium chloride; oral

2.2

6.0

273

K07

ICPC

Swollen ankles/oedema

2.3

6.0

231

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

6.7

6.0

TJA10

NOMESCO Finland

Laparocentesis

10.1

6.0

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

10.1

6.0

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

10.1

6.0

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

6.0

211

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.9

6.0

125

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

4.2

6.0

T89

ICPC

Diabetes insulin dependent

2.6

6.0

163

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

638

907

12.86

307.65

6.0

2.0

g/l

0.2

35.86

576

847

(3023183) Ammonium ion [Moles/volume] in Plasma

477

184

40.39

307.65

8.7

1.9

umol/l

49.3

30.8

10.95

438

150

(3007566) Smooth muscle Ab [Titer] in Serum

356

166

29.16

307.65

1.5

1.2

titre

79.8

81.5

0.03

(3028026) IgM [Mass/volume] in Serum or Plasma

400

530

10.46

301.43

1.9

1.8

g/l

1.5

1.4

0.24

372

486

(3005719) IgG [Mass/volume] in Serum or Plasma

434

687

8.99

281.31

2.8

2.9

g/l

12.2

10.5

6.29

408

625

(3006922) Hepatitis E virus Ab [Presence] in Serum

169

43.02

278.55

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

165

41.86

270.14

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

165

41.86

270.14

1.1

1.0

—

(40768441) Liver Pathology biopsy report

164

41.57

268.04

2.3

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

162

35.45

253.13

1.5

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

507

1122

6.77

235.47

11.1

2.5

umol/l

32.4

8.0

19.05

475

991

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

200

134

17.46

232.04

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

176

22.22

230.95

1.2

1.1

g/l

1.7

1.5

3.82

160

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

142

37.84

226.82

6.5

1.6

73.2

103.1

6.08

142

(3016650) Hepatitis A virus Ab [Presence] in Serum

193

128

17.53

224.95

1.2

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

450

952

6.70

217.11

14.0

7.2

mmol/l

11.1

10.0

2.05

433

904

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

220

199

13.11

214.20

6.0

5.6

iu/ml

17631.5

245.0

0.50

(3017143) Hepatitis C virus Ab [Presence] in Serum

439

960

6.40

203.36

1.8

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

471

1145

5.88

193.53

1.7

1.6

—

(3033799) Differential panel - Peritoneal fluid

97.34

190.10

2.3

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

101

68.36

184.41

1.6

1.1

g/l

9.4

17.0

1.67

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

59.45

176.35

2.3

1.3

e6/l

10575.6

6222.9

0.23

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

183

170

12.37

174.20

1.3

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

112

33.95

174.00

4.0

2.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

505

1439

5.11

169.62

10.2

5.6

mmol/l

1.1

1.0

1.50

480

1323

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

451

1179

5.33

167.84

2.8

1.8

1.7

1.5

7.49

391

1011

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

112

29.09

165.50

1.1

1.0

mg/l

293.5

295.0

0.03

105

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

174

163

12.17

164.51

1.3

1.2

u/ml

284.0

235.7

0.85

121

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

479

1388

4.88

155.87

3.4

2.6

28.7

22.5

6.84

412

1181

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

780

3275

4.46

154.24

12.2

3.0

u/l

94.1

32.7

9.70

751

3109

(3037522) Nuclear Ab [Titer] in Serum

443

1224

4.97

152.57

1.6

1.3

titre

383.5

452.5

0.50

114

253

(3004789) Transferrin [Mass/volume] in Serum or Plasma

490

1481

4.71

150.43

3.2

2.5

g/l

2.1

2.3

8.51

451

1369

(3012095) Magnesium [Moles/volume] in Serum or Plasma

533

1736

4.51

148.02

7.4

3.4

mmol/l

0.8

9.60

511

1625

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

121

17.69

144.82

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

157

152

11.61

144.82

2.5

3.2

u/ml

1506.6

1840.5

0.09

(3044007) Cell count panel - Peritoneal fluid

52.09

144.10

2.4

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

167

179

10.56

143.43

1.4

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

194

256

8.73

141.88

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

193

255

8.71

140.97

1.3

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

115

17.43

136.84

1.4

1.1

titre

184.0

76.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

498

1621

4.36

136.81

3.4

2.5

umol/l

13.4

12.8

0.77

469

1492

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

153

164

10.44

131.16

1.4

1.5

u/ml

121.9

106.0

1.01

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

24.05

129.89

1.9

2.1

umol/l

128.2

82.3

0.44

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

195

290

7.74

128.35

5.9

2.6

g/l

2.6

3.7

14.40

187

275

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

194

297

7.50

124.28

5.6

3.2

mg/l

1.8

1.6

2.24

185

272

(3024561) Albumin [Mass/volume] in Serum or Plasma

885

4534

3.99

121.41

15.3

4.6

g/l

31.2

35.4

60.00

848

4203

(44816559) Phosphatidylethanol [Mass/volume] in Blood

150

175

9.56

120.51

2.4

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

25.59

119.08

31.9

30.1

ug/l

128.1

135.3

0.20

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

714

3282

3.61

113.42

5.5

2.5

u/l

58.7

58.1

0.11

683

3037

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

973

5469

4.10

112.61

23.0

5.9

umol/l

32.4

11.3

32.05

941

5194

(3021879) Hepatitis B virus core Ab [Presence] in Serum

275

657

5.04

110.06

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

383

1218

4.04

105.21

3.9

4.3

u/l

292.7

245.9

1.79

362

1153

(3023368) Bacteria identified in Blood by Culture

660

3011

3.42

103.66

6.9

4.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

228

499

5.33

100.64

2.0

1.9

g/l

1.1

1.6

9.67

170

433

(3018677) aPTT in Platelet poor plasma by Coagulation assay

454

1689

3.59

97.94

4.1

2.1

32.1

29.8

7.62

441

1636

(3032080) INR in Blood by Coagulation assay

829

4441

3.40

97.86

20.2

9.5

inr

1.4

1.3

1.62

211

1266

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

28.74

93.32

1.0

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

471

1841

3.44

93.29

1.9

1.5

g/l

4.1

2.4

19.95

395

1073

(3042733) HLA Ab [Presence] in Serum

23.92

91.44

1.5

5.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

167

301

6.22

90.59

3.8

2.4

59.1

89.6

22.71

158

286

(3033658) Prothrombin time (PT) actual/Normal

585

2650

3.20

89.95

17.1

3.8

70.4

88.5

37.04

575

2593

(3024471) HLA-A [Type]

24.47

88.08

1.0

—

(3024932) HLA-DR beta [Type]

24.06

86.14

1.0

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

352

1220

3.59

83.10

3.2

2.6

2.5

1.8

9.84

314

1088

(3002032) Base excess in Venous blood by calculation

310

1000

3.76

81.44

6.9

3.5

mmol/l

1.0

2.0

2.87

231

783

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

208

504

4.72

80.55

6.8

3.8

mmol/l

23.2

24.1

2.64

195

455

(42870588) Differential panel, method unspecified - Blood

679

3512

2.96

79.90

9.6

5.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

309

1009

3.71

79.56

6.8

3.4

kpa

5.4

5.8

10.98

294

977

(3023520) Reticulocytes [#/volume] in Blood

291

913

3.82

79.49

3.3

2.8

e9/l

86.8

69.3

6.06

241

711

(4281824)

11.44

78.97

1.5

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

116

168

7.48

77.29

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

10.29

75.88

1.2

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

9.88

75.30

2.3

2.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

558

2666

2.92

74.94

3.2

2.1

mg/l

3.7

3.0

4.49

503

2250

(3042936) Bacteria identified in Isolate by Culture

390

1542

3.19

73.29

3.5

2.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

174

401

4.86

71.32

3.1

3.4

u/ml

54.2

3677.0

0.83

153

342

(3022217) INR in Platelet poor plasma by Coagulation assay

363

1398

3.22

71.07

22.3

26.7

inr

1.5

1.4

0.51

185

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

249

774

3.74

68.24

2.1

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

24.88

67.62

1.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

164

378

4.82

67.09

3.6

2.8

u/ml

0.3

0.4

1.72

217

(3000991) Gas panel - Venous blood

265

888

3.49

64.54

18.5

9.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

143

305

5.14

64.04

2.1

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

135

276

5.34

63.43

3.8

2.5

227.2

192.8

2.96

130

263

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

837

5250

2.67

61.61

17.5

6.9

mmol/l

1.2

12.62

736

4428

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

270

949

3.33

60.65

4.6

2.4

u/l

35.4

40.5

0.42

243

816

(3022096) Basophils/100 leukocytes in Blood

770

4694

2.57

59.24

10.8

5.9

0.7

0.92

740

4367

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

128

265

5.25

59.21

1.8

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

781

4798

2.57

59.03

15.9

6.3

mmol/l

1.2

16.65

743

4333

(3019069) Monocytes/100 leukocytes in Blood

785

4858

2.56

58.03

11.2

6.1

9.4

8.7

6.36

753

4535

(3006504) Eosinophils/100 leukocytes in Blood

782

4839

2.55

57.69

10.8

5.9

2.8

2.9

0.17

751

4492

(3002030) Lymphocytes/100 leukocytes in Blood

791

4963

2.52

55.97

10.9

6.0

24.9

27.4

7.67

759

4611

(3018010) Neutrophils/100 leukocytes in Blood

780

4882

2.50

55.18

10.3

5.8

58.6

57.5

1.65

750

4556

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

11.41

54.92

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

707

4245

2.46

54.64

4.7

2.7

ug/l

394.1

138.7

5.81

675

3883

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

9.98

54.28

1.2

1.3

—

(3006315) Basophils [#/volume] in Blood

804

5154

2.47

53.16

10.6

5.7

e9/l

0.0

0.36

723

4435

(3036489) Thrombin time

146

370

4.32

52.64

3.5

2.1

24.9

21.5

7.08

136

335

(3001604) Monocytes [#/volume] in Blood

798

5135

2.44

51.75

10.5

5.7

e9/l

0.6

1.65

718

4412

(3013115) Eosinophils [#/volume] in Blood

818

5333

2.44

51.33

11.1

6.0

e9/l

0.2

1.09

736

4678

(3019198) Lymphocytes [#/volume] in Blood

810

5262

2.43

51.17

10.6

5.8

e9/l

1.6

1.9

5.90

735

4610

(3014111) Lactate [Moles/volume] in Serum or Plasma

253

942

3.09

50.94

15.8

7.8

mmol/l

2.3

1.4

5.63

240

899

(3044640) Blood type and Crossmatch panel - Blood

593

3372

2.40

50.66

4.9

2.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

148

6.31

50.66

7.0

6.9

mg/l

12.7

11.7

0.75

135

(3024980) IgG subclass 4 [Mass/volume] in Serum

130

6.67

49.99

1.7

1.8

g/l

0.9

0.10

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

301

1263

2.80

48.55

19.0

8.5

kpa

4.8

5.1

6.01

284

1206

(3027801) Oxygen [Partial pressure] in Arterial blood

301

1263

2.80

48.55

19.0

8.5

kpa

11.5

12.0

1.24

285

1208

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

18.25

48.25

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

17.16

48.05

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

26.02

47.22

3.5

1.2

—

(3003396) Base excess in Arterial blood by calculation

297

1258

2.76

46.89

19.2

8.6

mmol/l

0.2

1.3

3.11

229

984

(46235355) HIV 1 and 2 tests - Meaningful Use set

331

1483

2.65

46.75

1.9

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

271

1097

2.86

46.62

3.1

4.1

ug/l

6.6

25.1

1.55

231

903

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

948

6770

2.48

46.01

12.9

2.9

u/l

153.9

48.4

34.09

912

6282

(3020191) Ethanol [Moles/volume] in Serum or Plasma

8.26

45.47

2.3

1.3

promille

0.6

1.2

1.97

(3016502) Oxygen saturation in Arterial blood

272

1130

2.78

44.37

20.4

9.0

96.0

95.6

0.61

264

1093

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

137

382

3.89

43.15

3.3

2.2

ug/l

918.5

493.5

0.73

126

359

(3018418) pH of Serum or Plasma

538

3097

2.26

42.80

7.2

4.0

7.4

1.54

113

592

(3013650) Neutrophils [#/volume] in Blood by Automated count

857

6001

2.26

41.24

15.2

9.0

e9/l

4.2

0.04

788

5240

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

119

310

4.12

41.14

1.5

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

467

2582

2.26

40.49

4.8

2.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

399

2065

2.35

40.47

2.1

1.8

nmol/l

1225.8

1194.1

0.25

311

1559

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

358

1791

2.38

39.05

2.2

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

190

696

3.03

38.75

6.3

3.6

mmol/l

1.2

1.8

1.36

138

522

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

147

462

3.46

38.65

3.4

1.9

ug/l

3.5

2.1

0.59

131

408

(3009343) pH of Capillary blood

195

726

2.98

38.64

6.3

3.6

7.4

1.85

(3026782) Osmolality of Urine

406

2162

2.28

38.14

3.6

2.7

mosm/kgh2o

512.3

559.0

4.35

367

1842

(3036481) Cortisol [Moles/volume] in Serum or Plasma

226

922

2.76

37.73

2.2

nmol/l

336.0

371.7

1.98

210

844

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

194

735

2.93

37.18

6.4

3.6

kpa

4.9

5.2

5.20

179

689

(3007853) Bacteria identified in Skin by Aerobe culture

270

1217

2.54

36.79

2.2

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

869

6271

2.17

36.62

15.2

5.0

mmol/l

7.3

6.7

6.32

839

5917

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

163

568

3.14

36.15

20.9

11.1

mmol/l

23.3

24.5

3.35

154

530

(3002173) Hemoglobin [Mass/volume] in Arterial blood

238

1030

2.60

35.17

22.9

9.5

g/l

110.4

121.2

10.54

231

998

(3024354) Oxygen [Partial pressure] in Venous blood

208

847

2.73

34.68

6.6

2.8

kpa

5.3

4.5

3.48

196

817

(3003181) Sodium [Moles/volume] in Urine

176

4.78

34.23

1.5

1.3

mmol/l

52.4

64.3

1.56

148

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1031

8120

2.31

32.67

25.9

7.2

u/l

127.0

78.1

45.06

1008

7619

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

159

580

2.98

32.45

27.7

12.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

208

880

2.62

32.00

2.4

2.9

g/l

63.9

66.6

3.30

182

797

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

712

4934

1.98

31.40

7.6

4.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

397

2247

2.10

30.90

2.8

1.7

mg/l

2.6

1.2

7.73

342

1739

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

597

3921

1.97

30.52

4.8

3.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

5.95

29.93

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

207

4.16

29.46

2.9

3.3

u/ml

1230.2

665.6

0.24

193

(3026008) Bacteria identified in Urine by Culture

495

3091

1.97

28.93

4.0

3.2

—

(3002582) Erythrocytes [#/volume] in Urine

518

3294

1.95

28.63

4.6

3.2

e6/l

156.1

91.0

0.36

444

2574

(3019060) Gas panel - Arterial blood

179

741

2.64

28.62

13.0

5.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

152

4.67

28.52

1.4

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

111

354

3.34

28.34

1.7

1.5

titre

108.0

185.5

—

(3022313) Gas panel - Capillary blood

143

540

2.85

27.26

7.3

3.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

183

793

2.52

26.54

5.3

3.8

ng/l

99.0

89.2

0.58

162

698

(3002179) Metamyelocytes/100 leukocytes in Blood

181

781

2.53

26.49

5.0

3.9

0.5

0.6

0.24

194

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

609

4171

1.87

26.13

3.5

2.2

nmol/l

72.8

77.2

2.86

561

3700

(4035726)

199

906

2.41

25.90

1.7

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

390

2314

1.98

25.87

3.3

2.5

e6/l

7.5

5.1

1.83

357

2043

(3026493) Urate [Moles/volume] in Serum or Plasma

455

2845

1.92

25.84

4.6

2.7

umol/l

4142.1

6079.6

0.45

405

2449

(3017181) Myelocytes/100 leukocytes in Blood

192

863

2.44

25.70

5.4

4.0

0.6

0.9

1.27

259

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

15.97

25.44

3.0

2.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

502

3275

1.87

24.77

2.9

2.2

u/l

293.8

233.6

0.62

483

3076

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

359

2097

1.98

24.74

1.4

1.2

u/ml

3.9

1.7

0.68

562

(40768797) Stomach Pathology biopsy report

266

1394

2.14

24.64

1.4

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

8.80

24.59

3.1

2.5

u/ml

1096.8

491.8

—

(3030467) Casts [#/volume] in Urine by Automated count

471

3020

1.88

24.47

4.4

3.1

e6/l

1.0

0.4

2.22

402

2307

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

124

464

2.85

23.98

8.1

4.0

mmol/l

24.5

25.0

0.72

116

437

(36304419) Bacteria [Presence] in Urine

455

2924

1.86

23.21

4.3

3.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

100

5.05

22.88

1.3

1.2

u/l

58.7

51.3

0.37

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

242

1256

2.14

22.84

2.1

1.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

157

678

2.50

22.81

23.1

10.6

0.7

0.53

157

673

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

150

634

2.54

22.80

1.7

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

167

4.04

22.80

3.5

4.1

1.0

1.5

0.60

140

(3018095) Leukocytes [#/volume] in Urine

551

3781

1.79

22.47

5.4

3.7

e6/l

90.5

119.0

0.43

453

2753

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

306

1742

1.99

22.42

3.7

2.9

e6/l

3.3

2.0

1.34

206

968

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

241

1260

2.12

22.27

2.2

1.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

176

816

2.34

21.81

5.6

4.1

0.0

0.1

2.12

238

(3008295) Osmolality of Serum or Plasma

114

4.62

21.39

1.4

1.5

mosm/kgh2o

274.2

278.4

0.54

(3047181) Lactate [Moles/volume] in Blood

332

3.04

21.35

19.4

8.0

mmol/l

1.9

1.3

1.97

295

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

154

683

2.42

21.07

23.0

10.5

1.5

1.4

0.87

154

678

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

215

3.54

21.06

1.7

1.6

—

(3012441) Differential panel - Pleural fluid

116

4.54

20.94

1.7

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

311

3.07

20.66

1.5

ug/g

217.2

293.4

2.24

184

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

611

4396

1.74

20.57

2.5

2.0

pmol/l

90.8

94.1

0.92

335

2299

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

183

3.69

20.05

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

145

3.99

19.44

1.7

1.4

g/l

25.3

31.8

3.12

130

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

115

461

2.64

19.42

17.1

6.3

2.0

1.6

3.03

103

437

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

476

3241

1.74

19.15

4.5

3.1

ng/l

2460.6

1468.2

2.96

420

2782

(1616796) Gas panel - Central venous blood

229

3.32

19.10

3.7

4.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

183

918

2.16

18.62

3.6

3.0

ng/l

343.5

218.2

1.75

170

843

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

214

1140

2.05

18.58

4.4

3.3

—

(1761868) Lipid panel - Serum or Plasma

214

3653

0.50

18.55

3.1

2.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

6.33

18.52

4.1

2.9

mg/l

336.7

72.4

0.45

(3027273) Bicarbonate [Moles/volume] in Venous blood

124

530

2.48

18.32

6.0

3.0

mmol/l

24.1

25.1

2.27

115

514

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

306

1851

1.85

18.23

3.5

2.7

e6/l

1.2

1.0

0.41

204

1073

(3004119) Hemoglobin [Mass/volume] in Venous blood

146

676

2.31

18.04

8.5

3.0

g/l

114.1

128.1

9.15

136

662

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

109

442

2.60

17.97

2.1

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

156

746

2.24

17.84

2.0

2.7

—

(3028707) Methadone [Presence] in Urine by Screen method

123

4.10

17.75

5.0

2.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

128

4.02

17.64

4.3

4.5

—

(3052851) Hemolysis interference index of Serum or Plasma

318

2.86

17.52

5.4

3.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

145

678

2.28

17.49

1.9

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

391

2572

1.74

17.46

1.9

1.6

nmol/l

18.6

20.5

1.80

350

2165

(4198724)

7.87

17.46

2.2

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

102

406

2.64

17.45

2.1

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

481

3349

1.69

17.45

4.1

3.1

mmol/l

7.0

7.7

3.10

422

2777

(3007930) Methemoglobin/Hemoglobin.total in Blood

110

455

2.55

17.41

17.7

6.4

0.9

0.24

431

(3037121) Protein [Mass/volume] in Urine

100

395

2.66

17.37

3.5

3.2

g/l

0.3

0.2

1.43

164

(3008152) Bicarbonate [Moles/volume] in Arterial blood

147

703

2.23

16.79

17.9

8.0

mmol/l

23.3

24.7

3.16

139

662

(3019225) pH of Specimen

197

1060

2.01

16.53

8.0

4.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

850

6910

1.67

16.40

6.7

4.4

e6/l

6443.5

2380.8

0.38

115

(4062490)

4.67

15.94

1.4

1.3

—

(3024928) Oxygen saturation in Venous blood

239

3.04

15.93

7.6

2.9

—

(3012501) Base excess in Blood by calculation

234

3.06

15.88

6.3

4.8

mmol/l

3.0

2.7

0.31

157

(3027135) IgG subclass 1 [Mass/volume] in Serum

4.72

15.70

1.4

1.3

g/l

7.6

6.5

0.74

(3028192) IgG subclass 2 [Mass/volume] in Serum

4.72

15.70

1.4

1.3

g/l

2.9

2.7

0.25

(3024139) IgG subclass 3 [Mass/volume] in Serum

4.72

15.70

1.4

1.3

g/l

0.5

0.3

1.64

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

131

3.77

15.51

2.3

2.4

33.2

32.8

0.20

131

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

322

2068

1.74

15.36

5.4

3.9

ng/l

264.6

413.5

0.81

271

1653

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

261

2.90

15.32

1.5

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

133

3.71

15.18

1.9

1.3

e6/l

1510.4

1660.1

0.09

(3028308) Erythrocytes [#/volume] in Pleural fluid

120

3.85

15.03

1.7

1.3

e6/l

29508.3

79447.1

0.49

(3025159) Blasts/100 leukocytes in Blood

152

769

2.11

15.02

5.5

4.2

0.0

0.5

0.68

204

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

4.32

14.86

1.5

1.3

—

(40758558) Short blood count panel - Blood

384

2610

1.67

14.76

12.0

6.7

—

(3000494) Fungus identified in Specimen by Culture

218

1259

1.88

14.75

2.3

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

384

2.50

14.28

2.2

2.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

4.41

14.10

4.3

2.2

umol/l

40.0

5.2

2.56

(3028626) Oxygen [Partial pressure] in Capillary blood

263

2.80

13.97

4.6

2.8

kpa

8.6

8.1

1.43

243

(3037756) Immunofixation for Serum or Plasma

235

2.91

13.96

1.4

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

5.09

13.87

2.2

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

5.09

13.87

2.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

4.09

13.87

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

250

2.82

13.57

25.6

9.0

mmol/l

106.0

105.4

0.34

229

(3039000) Anion gap in Blood

250

2.82

13.57

25.5

9.0

mmol/l

12.2

11.1

1.17

229

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

5.51

13.56

1.0

u/l

58.8

27.6

1.16

(1001926) Buprenorphine [Presence] in Urine by Screen method

206

3.01

13.54

4.5

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

115

3.74

13.53

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

4.92

13.36

1.8

1.6

u/l

5.1

8.7

0.41

(3010421) pH of Blood

287

2.67

13.34

6.1

4.3

7.4

1.09

231

(40767503) Oxygen content in Capillary blood by calculation

227

2.87

13.05

3.0

2.5

14.5

16.3

1.88

117

(3017354) Segmented neutrophils/100 leukocytes in Blood

105

3.80

12.88

3.7

3.8

58.7

52.3

0.70

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

550

4179

1.55

12.85

5.4

3.8

ng/l

78.3

63.3

0.23

452

3001

(40760888) Immunoglobulin light chains.free panel - Serum

252

2.75

12.82

2.0

3.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

862

7233

1.57

12.78

6.8

4.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.75

12.39

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

251

2.72

12.37

1.6

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

223

2.82

12.32

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

223

2.82

12.32

1.4

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

6.87

12.32

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

213

2.80

11.63

1.6

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.57

11.45

1.4

1.3

—

(3011288) Drugs identified in Urine by Screen method

187

2.91

11.43

5.4

2.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

345

2.37

11.14

1.9

3.7

mg/l

74.6

70.9

0.06

280

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

339

2.38

11.12

1.9

3.7

ratio

1.4

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

451

3363

1.52

11.06

4.2

3.9

mg/mmol

16.8

8.0

2.89

320

2110

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

347

2.36

11.00

1.9

3.7

mg/l

42.4

55.7

0.34

283

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

953

10548

0.64

10.86

5.7

5.0

mmol/l

2.4

2.7

16.21

873

9674

(3042111) Morphology [Interpretation] in Bone marrow Narrative

182

2.88

10.79

1.5

1.7

—

(3012516) Albumin [Mass/volume] in Urine

430

3190

1.52

10.74

3.6

3.2

mg/l

459.3

265.2

0.41

311

2022

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

240

2.62

10.73

1.5

1.4

—

(3026361) Erythrocytes [#/volume] in Blood

1076

11572

0.59

10.66

59.1

21.4

e12/l

4.1

4.5

72.83

1049

11248

(3027456) Digoxin [Moles/volume] in Serum or Plasma

247

2.59

10.63

3.1

3.2

nmol/l

0.9

0.01

193

(3016879) Cocaine [Presence] in Urine

247

2.59

10.63

5.1

1.8

—

(3035941) MCH [Entitic mass]

1076

11570

0.59

10.60

58.9

21.3

30.7

30.4

4.72

1059

11390

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

327

2290

1.57

10.58

1.9

1.7

pmol/l

577.1

26586047.8

1.88

279

1892

(3028433) Virus identified in Specimen by Culture

5.83

10.55

1.4

—

(3051651) Icteric interference index of Serum or Plasma

4.04

10.52

7.1

3.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

1077

11575

0.59

10.51

59.7

21.6

g/l

123.1

135.7

85.40

1058

11391

(3017732) Neutrophils [#/volume] in Blood

129

699

1.94

10.47

3.5

2.8

e9/l

4.2

4.1

0.18

533

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

427

2.19

10.45

2.2

2.0

u/l

48.5

39.6

1.74

377

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

151

864

1.85

10.37

3.3

2.7

ml/min/173m2

52.9

65.3

3.03

362

(3024731) MCV [Entitic volume]

1077

11570

0.60

10.36

58.9

21.3

92.4

91.2

8.56

1059

11392

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

933

10349

0.65

10.32

5.5

4.5

mmol/l

4.3

4.6

16.61

861

9561

(3007461) Platelets [#/volume] in Blood

1077

11567

0.60

10.27

59.1

21.4

e9/l

210.6

245.9

37.01

1050

11273

(3010813) Leukocytes [#/volume] in Blood

1078

11575

0.60

10.27

59.1

21.4

e9/l

7.0

6.8

2.80

1052

11251

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

926

10284

0.65

10.25

5.4

4.4

mmol/l

1.3

1.4

12.31

849

9420

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

320

2.36

10.22

1.6

1.8

—

(3021901) Oxygen saturation in Capillary blood

202

2.69

9.93

2.8

2.6

—

(40768806) Pleura Pathology biopsy report

120

3.23

9.92

1.7

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

26.23

9.82

1.2

1.4

—

(3045788) Cell count panel - Pleural fluid

106

3.37

9.76

2.0

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

166

996

1.76

9.73

2.5

ug/l

9.6

7.2

0.69

141

872

(40760892) CBC W Ordered Manual Differential panel - Blood

318

2254

1.54

9.63

7.3

4.4

—

(3016038) Potassium [Moles/volume] in Urine

3.97

9.61

1.3

1.2

mmol/l

29.7

36.2

0.75

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

5.06

9.58

1.4

1.3

69.6

54.8

0.86

(3015377) Calcium [Moles/volume] in Serum or Plasma

469

3606

1.47

9.58

4.6

3.3

mmol/l

2.3

2.4

9.97

407

3127

(3000764) Benzodiazepines [Presence] in Urine

267

2.43

9.52

5.1

1.8

—

(3028300) Cannabinoids [Presence] in Urine

268

2.42

9.44

5.1

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

185

2.71

9.37

1.4

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

191

2.68

9.35

1.4

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

290

2.34

9.21

3.1

2.8

mmol/l

22.6

24.9

2.95

254

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

205

2.60

9.14

1.2

u/ml

1.0

8.2

—

(3027008) Opiates [Presence] in Urine

268

2.38

8.98

5.1

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

118

3.11

8.86

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

162

2518

0.59

8.83

2.6

3.0

ug/l

0.7

0.8

0.14

114

1654

(3045142) Bone marrow Pathology biopsy report

124

3.04

8.78

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

5.37

8.69

19.8

7.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

115

3.10

8.59

1.9

—

(3021589) Normoblasts [#/volume] in Blood

571

4623

1.42

8.57

19.4

9.4

e9/l

0.0

0.41

487

3774

(3009871) Measles virus Ab [Titer] in Serum

5.57

8.51

1.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

7.56

8.42

1.4

1.1

63.6

82.6

—

(36660697) Celiac disease serology panel - Serum

129

750

1.80

8.40

1.2

—

(21494755) Public health laboratory ask at order entry panel

859

0.36

8.27

1.1

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

102

3.19

8.26

1.7

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

267

2.31

8.16

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

3.61

8.15

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

3.61

8.15

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

3.61

8.15

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

158

2.71

8.12

1.3

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

9.15

8.09

1.2

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

7.12

8.00

1.4

1.1

69.6

73.0

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

7.92

7.99

1.0

1.5

mmol/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

126

2.91

7.95

1.6

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

110

3.05

7.92

7.5

3.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

140

849

1.73

7.88

6.0

3.8

mmol/l

1.2

4.77

134

736

(3027944) Amphetamines [Presence] in Urine

265

2.28

7.87

4.7

1.8

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

3.52

7.84

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

3.52

7.84

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

3.52

7.84

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

127

2.89

7.84

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

127

2.89

7.84

1.6

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.82

7.81

1.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

122

2.92

7.79

4.2

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

117

2.96

7.74

1.3

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

128

2.86

7.73

1.6

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

128

2.86

7.73

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

128

2.86

7.73

1.6

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

3.47

7.69

1.8

1.4

u/l

21.2

13.8

1.30

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

107

3.04

7.65

1.6

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

842

0.38

7.64

1.6

1.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

18.47

7.60

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

100

555

1.87

7.57

1.4

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.70

7.48

1.4

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

4.44

7.44

1.7

2.0

ug/l

127.1

68.0

0.78

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.05

7.36

1.5

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.05

7.36

1.5

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

5.43

7.26

1.6

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

15.84

7.23

1.9

1.1

—

(3044927) Protein electrophoresis panel - Urine

122

2.83

7.20

1.4

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

373

2.01

7.05

1.5

2.7

g/l

3.0

3.1

0.37

294

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

226

2.31

7.04

1.3

1.6

nmol/l

0.9

0.8

0.28

191

(3020891) Body temperature

444

1.93

7.03

8.2

4.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

906

9928

0.71

7.01

5.1

4.0

mmol/l

1.4

1.3

1.19

834

9041

(3013707) Erythrocyte sedimentation rate by Westergren method

874

7754

1.39

6.94

6.8

4.0

mm/h

19.4

12.3

21.85

827

7127

(44790049)

125

2.77

6.90

1.5

1.6

—

(44790047)

125

2.77

6.90

1.5

1.6

—

(44806118)

125

2.77

6.90

1.5

1.6

—

(44790048)

125

2.77

6.90

1.5

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

222

2.30

6.88

2.1

2.2

g/l

117.3

131.6

3.51

167

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

937

10188

0.71

6.65

5.6

4.7

mmol/l

6.3

6.0

6.85

858

9238

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

260

3463

0.69

6.63

3.7

4.3

22.5

21.3

0.38

1666

(3035880) pH of Pleural fluid

3.48

6.58

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

164

2.48

6.56

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

202

2.32

6.50

4.3

3.0

e9/l

3.4

4.4

2.46

202

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

569

0.31

6.50

1.3

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

3.10

6.49

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

209

2.30

6.46

4.6

3.3

56.2

57.9

0.47

209

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

191

2.35

6.39

2.9

2.2

u/l

308.0

3972.5

1.72

(3003694) ABO and Rh group [Type] in Blood

356

2764

1.40

6.38

1.7

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

119

2.73

6.37

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

1.91

6.30

1.5

2.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

1.91

6.30

1.5

2.7

g/l

4.0

3.8

0.63

289

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

1.91

6.30

1.5

2.7

g/l

7.1

7.3

0.36

301

(3029075) Extractable nuclear Ab panel - Serum

4.25

6.29

1.1

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.49

6.02

1.5

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

5.26

6.01

1.5

1.2

29.6

25.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

3.37

6.01

1.4

nmol/l

1.3

1.1

0.51

(3013512) EKG study

399

3183

1.37

6.00

5.1

3.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

4.55

5.99

14.9

7.7

—

(3052592) Norovirus Ag [Presence] in Stool

6.29

5.96

2.0

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

11.19

5.80

1.4

1.0

—

(40768446) Kidney Pathology biopsy report

4.41

5.77

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

281

2.04

5.73

2.1

mg/l

12.1

11.8

0.10

254

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

344

1.94

5.73

1.5

3.0

g/l

0.8

1.5

0.87

300

(3014891) Appearance of Pleural fluid

5.92

5.63

3.1

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

122

2.58

5.57

1.3

1.8

—

(3048879) Bone marrow aspiration report

4.28

5.56

1.1

2.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

377

1.88

5.54

1.5

2.8

g/l

12.6

10.5

1.54

322

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.84

5.50

1.8

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.84

5.50

1.3

1.6

64.6

97.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.84

5.50

2.2

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.84

5.50

1.2

1.1

54.3

93.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

265

2.04

5.49

1.3

1.2

u/ml

3.3

10.4

0.71

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.37

5.45

1.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

287

1.99

5.42

1.6

3.0

g/l

0.0

0.00

261

(3027974) Hepatitis B virus e Ag [Presence] in Serum

16.09

5.41

1.1

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

302

1.96

5.37

1.6

3.0

g/l

0.0

0.86

276

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.74

5.29

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.74

5.29

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.74

5.29

1.6

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

284

1.98

5.23

1.6

3.0

g/l

0.0

0.00

260

(21494434) Karyotype in Bone marrow

103

2.66

5.17

1.1

1.2

—

(3011412) CD3 cells [#/volume] in Blood

2.82

5.16

1.8

2.1

e9/l

0.9

1.2

0.76

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

261

1.99

4.98

1.3

1.1

u/ml

2.1

2.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

148

2.33

4.97

1.4

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

319

1.89

4.92

1.6

2.8

g/l

33.9

37.5

3.38

273

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.25

4.90

5.9

3.1

u/ml

3233.1

1495.3

0.79

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.81

4.82

1.5

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.81

4.82

2.1

1.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.05

4.78

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

4.61

4.78

15.2

8.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

5.03

4.78

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

5.03

4.78

1.6

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.97

4.71

1.5

1.3

ug/l

15.6

9.0

1.62

(3002256) Pathology report gross observation

184

1339

1.44

4.67

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.13

4.65

1.4

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

353

4281

0.76

4.60

4.0

5.0

ug/l

2.5

2.9

0.29

314

3826

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.85

4.54

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.85

4.54

1.3

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

10.05

4.52

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.18

4.49

1.6

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.18

4.49

2.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.18

4.49

1.6

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.18

4.49

1.6

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.18

4.49

1.6

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

149

2.25

4.46

1.3

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.95

4.45

1.9

2.3

e6/l

423.5

471.4

0.16

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

244

1.96

4.44

1.4

1.3

miu/ml

299.6

198.3

—

111

(3022145) Colonoscopy Study observation

158

1134

1.45

4.32

1.4

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

4.57

4.30

2.5

1.8

e6/l

18.0

259.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.64

4.21

1.3

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.44

4.19

1.5

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

317

1.80

4.09

1.6

iu/ml

300.1

20.9

0.43

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.88

4.07

1.9

2.3

e9/l

0.2

0.04

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.54

4.05

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

10.05

4.01

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.46

3.98

1.6

2.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.56

3.98

1.4

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

2.84

3.96

1.9

14.8

12.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

157

2.13

3.96

1.1

iu/ml

20.3

112.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

443

0.40

3.94

1.9

1.7

—

(3042631) Mycobacterium sp identified in Specimen

151

2.15

3.92

2.0

2.5

—

(3048689) Calprotectin [Mass/mass] in Stool

153

1112

1.43

3.91

2.8

2.2

ug/g

223.4

131.5

1.27

126

888

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.66

3.91

2.4

2.8

36.3

43.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.45

3.90

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

2.91

3.90

1.0

1.3

nmol/l

157.6

146.8

0.30

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.99

3.85

1.6

2.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

2.45

3.81

1.2

1.4

nmol/l

1.1

1.4

0.65

(3044290) Cell count panel - Cerebral spinal fluid

201

1.97

3.80

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.86

3.80

1.4

1.6

—

(3042517) Benzodiazepines panel - Urine

8.79

3.77

3.0

2.4

—

(3000012) Reticulocyte production index

3.02

3.69

2.4

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

162

2.06

3.68

1.2

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.49

3.64

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.45

3.62

1.3

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

247

0.32

3.60

1.3

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1062

11113

0.76

3.55

31.4

10.2

u/l

61.0

26.4

8.77

1044

10707

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

131

2.16

3.53

3.0

2.3

mg/l

24.2

22.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.18

3.50

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

10.04

3.50

1.0

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.56

3.47

1.3

1.4

u/ml

11.5

20.0

—

(3003338) MCHC [Mass/volume]

806

8700

0.81

3.43

52.7

18.9

g/l

332.2

332.6

0.54

796

8634

(3014271) Vancomycin [Susceptibility]

2.59

3.39

4.0

2.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.72

3.35

1.0

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.74

3.34

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.74

3.34

1.1

—

(40768804) Tissue Pathology biopsy report

472

4101

1.24

3.30

2.5

2.1

—

(4306422)

135

2.10

3.29

1.4

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.18

3.21

1.2

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.36

3.19

1.4

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.36

3.19

9.9

9.8

mmol/l

9.9

6.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

6.39

3.18

1.0

—

(40761535) Cells panel - Urine sediment

124

902

1.41

3.18

5.5

3.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

144

2.04

3.17

1.3

1.2

u/ml

3.9

2.5

—

(3011648) Oxygen content in Venous blood

2.43

3.14

3.9

1.6

9.5

10.8

0.67

(40768443) Skin Pathology biopsy report

455

1.57

3.12

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.30

3.11

1.6

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

188

1.89

3.08

1.8

1.3

u/l

94.5

44.3

0.58

159

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

232

1.79

3.07

1.4

e6/l

3.0

47.9

1.09

185

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

232

1.79

3.07

1.5

1.4

e6/l

330.3

665.7

0.30

190

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

5.02

3.05

1.3

1.0

—

(40761511) CBC panel - Blood by Automated count

1038

10851

0.78

3.01

37.7

13.9

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

10.03

2.98

2.8

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.48

2.96

1.7

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

570

1.49

2.90

2.6

3.4

pmol/l

4.1

4.5

1.53

506

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

5.41

2.87

1.3

1.1

u/l

14.3

28.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.69

2.87

1.3

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

2.94

2.86

1.8

1.1

—

70.0

—

(4268621)

2.21

2.84

2.5

2.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.78

2.82

1.7

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

2.24

2.81

1.0

1.4

—

35.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.41

2.80

1.4

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

110

2.11

2.79

1.3

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.87

2.75

1.7

2.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.02

2.73

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.73

2.72

1.2

1.1

ratio

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.52

2.70

1.5

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.52

2.70

3.1

3.9

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

2.30

2.68

1.3

1.1

u/ml

35.2

37.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

176

1.84

2.65

3.8

3.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

170

1341

1.31

2.63

4.7

4.5

33.5

32.4

0.60

139

897

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

148

1.91

2.62

1.3

1.2

u/ml

4.2

6.8

0.52

(40768800) Prostate Pathology biopsy report

275

0.39

2.59

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

284

1.64

2.57

2.3

2.4

ug/min

208.3

86.5

0.73

168

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.02

2.57

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

142

1.92

2.57

2.4

2.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

7.17

2.55

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

7.17

2.55

1.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1124

0.70

2.48

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.84

2.48

1.3

1.0

miu/ml

1717.9

1711.5

0.01

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

304

1.60

2.44

1.4

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

5.02

2.40

2.0

3.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

306

1.59

2.38

1.4

1.2

—

(3025315) Body weight

6.27

2.37

8.2

3.6

—

(4212803)

6.27

2.37

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

2.52

2.36

4.9

14.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.39

2.29

1.1

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.70

2.28

1.6

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.70

2.28

1.6

2.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

310

1.57

2.27

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

106

2.00

2.26

1.3

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

551

1.42

2.23

2.5

2.4

—

(3034426) Prothrombin time (PT)

3.12

2.22

1.3

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

100

2.02

2.21

1.9

2.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

114

1.95

2.21

1.2

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.51

2.19

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.30

2.15

1.7

2.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

238

0.42

2.14

1.6

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

116

1.91

2.11

1.3

1.1

—

(3004775) Volume in Urine collected for unspecified duration

2.01

2.11

2.1

2.3

636.0

646.9

0.04

(3023511) Choriogonadotropin [Units/volume] in Urine

109

1.94

2.11

1.4

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

929

9729

0.84

2.07

8.3

5.9

mmol/mol

40.7

40.1

1.02

869

8951

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.01

2.07

1.2

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

5.01

2.07

1.2

1.5

—

(1002224) Polysomnography panel

415

0.57

2.03

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

360

1.49

2.03

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

247

1.60

2.03

1.4

1.5

u/l

7.3

9.4

0.54

200

(21494890) Protein electrophoresis panel - 24 hour Urine

105

1.92

1.96

1.6

2.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.76

1.93

1.3

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

141

0.35

1.88

1.6

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

2.04

1.85

1.3

1.4

mmol/l

11.0

11.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

560

6062

0.87

1.81

3.0

2.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.93

1.80

1.7

2.3

u/field

2.9

1.9

0.29

(3016750) Collection duration of Urine

2.04

1.75

2.0

2.2

min

508.6

498.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

110

1.83

1.73

1.5

pmol/l

563.9

307.4

0.70

(3005570) Glucose [Moles/volume] in Urine

111

1.81

1.69

1.9

2.1

—

(3044941) Cell count panel - Synovial fluid

172

1.64

1.68

1.3

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

162

0.43

1.67

1.6

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.87

1.66

1.2

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.17

1.66

4.2

1.5

mmol/l

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.58

1.61

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.58

1.61

1.8

2.6

—

(3017704) Immunofixation for Urine

2.07

1.60

1.2

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

136

1.70

1.59

1.3

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

234

2027

1.19

1.59

3.6

3.1

mmol/l

2.5

2.4

2.56

191

1783

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.70

1.58

3.0

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.70

1.58

1.6

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

138

1.68

1.52

1.3

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.60

1.51

1.6

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.87

1.50

1.5

1.2

—

(4034850)

331

0.60

1.50

23.1

10.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

953

9879

0.87

1.47

34.5

13.5

ml/min/173m2

74.6

79.3

6.30

861

8187

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.85

1.46

1.6

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.51

1.45

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.12

1.44

1.8

1.3

—

(40757373) Influenza virus identified in Isolate

2.73

1.43

1.3

2.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

580

1.31

1.43

1.4

1.2

u/ml

276.5

204.4

0.33

532

(4094501)

289

0.58

1.42

1.4

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.95

1.36

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.88

1.34

3.5

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.14

1.34

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.51

1.30

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

231

0.56

1.29

1.8

2.2

—

(3035350) Ketones [Presence] in Urine by Test strip

547

5106

1.12

1.28

5.4

3.6

estimate

0.0

0.00

117

955

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

125

1483

0.83

1.25

1.3

1.4

—

(3047189) Immunofixation for 24 hour Urine

2.05

1.22

1.4

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

912

9441

0.89

1.21

5.2

4.6

mu/l

2.1

0.07

846

8564

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

156

1.55

1.20

2.0

1.6

—

(40761536) Microorganisms panel - Urine sediment

108

895

1.23

1.20

5.0

3.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.31

1.18

1.2

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.31

1.18

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.31

1.18

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.31

1.18

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.31

1.18

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

134

1.58

1.14

2.8

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.85

1.13

1.2

3.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.85

1.13

1.3

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1.90

1.12

25.4

21.3

nmol/l

1561.2

1574.2

0.02

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.39

1.09

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.39

1.09

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.74

1.09

1.2

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.83

1.09

1.3

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

144

1.54

1.09

4.0

2.5

mmol/l

4.1

0.19

144

(3035285) Chloride [Moles/volume] in Venous blood

144

1.54

1.09

4.0

2.5

mmol/l

105.6

105.5

0.01

144

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.96

1.09

3.1

3.8

u/l

224.4

210.3

—

(3044889) 12 lead EKG panel

717

7499

0.90

1.08

4.7

4.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

105

1.63

1.06

1.1

1.4

e6/l

482060.0

107904.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

280

1.37

1.05

6.2

5.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1.92

1.02

1.1

1.2

mmol/l

6.1

6.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

262

2384

1.12

0.93

5.3

3.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.72

0.92

4.0

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

244

0.65

0.92

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

262

1.35

0.90

1.4

1.8

e6/l

25875.0

17949.6

0.29

194

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.87

0.87

2.3

4.0

—

(3019150) Specific gravity of Urine by Refractometry

249

2274

1.12

0.84

6.6

4.0

kg/l

1.0

0.32

319

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.78

0.84

1.0

1.1

—

(4146454)

121

1.49

0.83

3.9

2.6

—

(3029937) Albumin [Presence] in Urine by Test strip

301

2781

1.11

0.82

6.4

3.9

estimate

0.0

0.69

108

924

(3022621) pH of Urine by Test strip

664

1.20

0.82

4.3

3.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.88

0.82

3.2

3.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.88

0.82

3.2

3.1

—

(40768793) Breast Pathology biopsy report

213

0.65

0.81

1.1

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1068

10883

0.90

0.80

50.7

17.2

mmol/l

4.0

0.04

1044

10593

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.82

0.79

1.3

2.6

—

(4211845)

1.67

0.78

2.5

3.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.52

0.78

1.0

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

757

0.82

0.78

1.3

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

485

1.23

0.77

1.4

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

141

1.42

0.74

4.3

2.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

367

0.76

0.72

2.0

1.8

mg/l

4.3

4.4

0.02

270

(3017569) Oxygen content in Arterial blood

1.67

0.72

1.4

3.1

—

(3000492) Spirometry study

113

993

1.15

0.71

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.93

0.70

1.0

1.2

—

17.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.93

0.70

1.0

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.71

0.70

2.7

2.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

621

1.19

0.69

1.1

1.2

iu/ml

107.6

148.0

0.59

245

(4024509)

1.51

0.69

2.0

1.5

—

(3006462) Nitrate [Presence] in Urine

1.67

0.68

2.7

3.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.53

0.68

1.1

1.4

ug/l

5.7

2.7

—

(3008898) HLA-B27 [Presence]

326

0.76

0.64

1.2

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

533

5102

1.08

0.64

7.2

4.9

estimate

0.0

0.50

119

960

(3009261) Glucose [Presence] in Urine by Test strip

539

5163

1.08

0.64

5.5

3.6

estimate

0.0

0.80

118

927

(3041096) Erythrocytes [Presence] in Urine by Automated

295

2761

1.09

0.63

4.9

3.3

—

(3004451) EKG impression Narrative

1.59

0.62

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

113

1.42

0.61

1.3

1.6

—

(3021788) Differential panel - Synovial fluid

200

1.31

0.61

1.4

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.60

0.0

1.1

—

25.5

—

(3049717) Cytology report of Urine Cyto stain

473

1.19

0.60

2.5

2.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1060

10424

1.09

0.59

42.1

14.6

mg/l

24.2

25.5

0.82

992

8283

(3019550) Sodium [Moles/volume] in Serum or Plasma

1069

10853

0.92

0.58

50.7

17.0

mmol/l

138.2

139.7

42.04

1046

10578

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.62

0.55

2.2

3.0

—

(44813793)

1.41

0.51

1.1

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

840

8574

0.94

0.46

50.2

17.7

15.1

13.7

64.18

826

8384

(40768795) Lymph node Pathology biopsy report

103

1.36

0.45

1.3

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1.40

0.44

2.8

2.3

e6/l

613.3

640.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.43

0.41

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.47

0.40

1.6

1.9

—

(44806420)

1.47

0.40

2.6

2.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

763

7790

0.95

0.39

4.4

3.8

pmol/l

14.8

14.9

0.16

698

7026

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

171

0.76

0.39

1.3

1.1

—

14.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

258

0.81

0.38

1.7

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.35

0.37

1.6

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

621

1.12

0.36

1.3

—

51.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

235

1.20

0.36

2.3

1.8

iu/l

2.1

5.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

651

1.11

0.35

1.5

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.62

0.35

1.0

1.1

—

(4010399)

767

1.10

0.35

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

643

1.11

0.34

1.1

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.28

0.32

1.0

1.1

iu/ml

279.8

223.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

305

0.85

0.31

2.3

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

930

9422

0.95

0.31

44.5

15.8

36.2

39.9

23.14

599

6605

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.35

0.31

1.3

1.2

ug/l

7.1

6.4

—

(3025130) Human papilloma virus identified in Specimen

1.30

0.28

2.6

1.8

—

(3045414) Leukocytes [Presence] in Urine

446

0.89

0.26

1.6

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

157

1644

0.95

0.23

1.3

1.2

u/ml

6.1

12.4

1.12

624

(3045424) Erythrocytes [Presence] in Urine

172

1.17

0.22

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

293

0.89

0.21

2.5

1.8

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

114

0.79

0.20

5.9

2.2

13.7

13.2

—

114

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

260

1.12

0.19

1.7

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

118

1.19

0.19

3.6

3.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.13

0.18

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

689

1.06

0.17

2.5

—

18.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

140

1347

1.04

0.17

16.9

7.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.71

0.16

4.8

2.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

116

1208

0.96

0.16

1.6

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

130

1.16

0.15

1.4

1.6

81.4

61.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

810

1.05

0.15

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

150

1.14

0.14

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

150

1.14

0.14

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

141

1.14

0.14

1.5

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

885

1.04

0.12

2.0

2.2

nmol/l

12.9

12.8

0.03

784

(3047007) Chlamydophila sp Ab [Presence] in Serum

133

1.13

0.12

1.8

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

364

0.93

0.12

2.6

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

400

3948

1.02

0.10

6.1

3.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

1.09

0.09

1.4

1.1

—

369.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

145

1.10

0.09

1.5

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1.14

0.09

1.4

1.3

8.8

30.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

302

1.06

0.08

1.3

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

313

1.06

0.07

1.6

1.4

iu/l

21.1

27.5

0.68

270

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

327

0.95

0.07

2.1

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

173

1700

1.02

0.07

1.3

iu/ml

51.6

33.7

0.82

525

(3003888) Timothy IgE Ab [Units/volume] in Serum

132

0.91

0.06

1.2

1.0

u/ml

5.7

5.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

286

2833

1.01

0.05

2.0

1.6

mmol/l

1.5

1.4

0.87

257

2353

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

475

0.97

0.05

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

268

1.05

0.04

1.4

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

271

0.96

0.04

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

129

0.93

0.03

1.2

1.0

u/ml

2.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

127

0.94

0.01

1.6

1.3

nmol/l

0.7

0.6

0.42

119

(3000330) Specific gravity of Urine by Test strip

526

0.99

0.00

5.4

3.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

736

0.99

0.00

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

148

1.01

0.00

1.1

u/ml

0.3

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

235

0.98

0.00

4.2

3.8

mg/l

32.1

25.7

0.34

147

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

135

1.04

0.00

1.1

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

115

1.04

0.00

1.6

1.3

nmol/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.6

—

14.1

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(4027681)

1.00

0.00

1.2

1.1

—

(3024263) Appearance of Synovial fluid

1.00

0.00

1.3

1.6

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

7.8

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.2

—

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.90

0.00

1.0

1.2

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

21.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.0

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.6

—

2.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

120

1.00

0.00

1.8

1.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

39.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1484.2

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.5

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

2.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.8

—

9.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

330.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.02

0.00

3.3

7.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.2

—

388.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_HEPFAIL and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_HEPFAIL	5.676 [4.64, 6.95]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.734

During the follow-up period (1.1.1998 — 31.12.2019), 1261 out of 2843 females with K11_HEPFAIL died.

Males

Parameter	HR [95% CI]	p-value
K11_HEPFAIL	8.309 [6.57, 10.51]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1973 out of 3664 males with K11_HEPFAIL died.

Mortality risk

Mortality risk for people of age

years, who have K11_HEPFAIL.

N-year risk	Females	Males
1	0.605%	0.979%
5	3.398%	8.39%
10	9.095%	20.469%
15	16.851%	36.282%
20	27.438%	53.177%

Relationships between endpoints

↥

Index endpoint: K11_HEPFAIL – Hepatic failure, not elsewhere classified

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hepatic failure, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints